Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Skinbiotherap. Share Price (SBTX)



Share Price Information for Skinbiotherap. (SBTX)


Share Price: 10.50Bid: 10.25Ask: 10.75Change: 0.00 (0.00%)No Movement on Skinbiotherap.
Spread: 0.50Spread as %: 4.88%Open: 9.75High: 10.50Low: 9.75Yesterday’s Close: 10.50

Skinbiotherapeutics Plc Ord 1P

Skinbiotherap. is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
10.50

Share Price SpacerBid
10.25

Share Price SpacerAsk
10.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
547,018

Share Price SpacerOpen
9.75

Share Price SpacerHigh
10.50

Share Price SpacerLow
9.75

Share Price SpacerClose
10.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 118.71m £12.46m 10,000

52 Week High 17.75 52 Week High Date 7-APR-2017
52 Week Low 8.88 52 Week Low Date 22-AUG-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
18 101,041 322,335 -9.459 -1.11 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Oct-17
17:08:06
10.50
30,000
 
10.25
10.75
3,150
Trade Type:
Ordinary

20-Oct-17
16:17:29
10.325
26,033
Sell* 
10.25
10.75
2,688
Trade Type:
Ordinary

20-Oct-17
14:43:12
10.74
5,000
Buy* 
10.25
10.75
537.00
Trade Type:
Ordinary




View more Skinbiotherap. trades >>

Directors Deals for Skinbiotherap. (SBTX)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Catherine Anne O'Neil held the position of CEO at SkinBioTherapeutics at the time of this trade.
 Catherine Anne O'Neil
005256989
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Martin Braddock Hunt held the position of Non-Executive Chairman at SkinBioTherapeutics at the time of this trade.
 Martin Braddock Hunt
00444444
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Douglas John Quinn held the position of CFO at SkinBioTherapeutics at the time of this trade.
 Douglas John Quinn
00444444
View more Skinbiotherap. directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Fri 16:30porthlevenAccumulate10.50Strong Buy
OPTI is my largest holding, hope SBTX stays at these levels for a while yet, I keep accumulating when fund's allow this is going to go the same way as OPTI.
GLA.
Fri 15:56CostelloShares.10.50No Opinion
When do opti shareholders get their skin bio shares?
Fri 15:33Hugh-JarseRE: Share.10.50No Opinion
Last I heard was SOH saying he was still working out the allocation
and we would know soon. Part of the interview with TW a while back.

If there's been more recent progress, jump in please. Hugh.
Fri 14:29CostelloShare.10.50Buy
When do these get dished out to opti shareholders?
Mon 22:06elricoSunday Times magazine about Microbi9.75No Opinion
THE BEAUTY OF BIO
WE KNOW PROBIOTICS CAN HELP YOUR
DIGESTION BUT WHAT CAN THEY DO FOR YOUR SKIN
CLAIRE COLEMAN INVESTIGATES

With the hottest health-food books of the year invariably featuring the
word "gut" or "microbiome", we've become quite au fait with probiotics
and looking after the "good bacteria" in our stomachs. The latest figures
suggest that whether we're popping a supplement after a course of antibiotics, replacing our regular yoghurt with… Read More
5 Oct '17AndykenRE: Results RNS10.125No Opinion
Shame that the market hasn't responded positively. It looks as if there are some people range trading between 9 and 12.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Skinbiotherap. (SBTX) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.